(Q48643095)

English

Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice

scientific article published in January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

0 references

experimental autoimmune encephalomyelitis

1 reference

based on heuristic

inferred from title

16

object named as

Thomas Unger

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

Ulrike Steckelings

18

object named as

U Muscha Steckelings

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

12

object named as

Ludovit Paulis

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

Pawel Namsolleck

3

object named as

Pawel Namsolleck

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

17

object named as

Colin Sumners

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

Christa Thoene-Reineke

13

object named as

Christa Thoene-Reineke

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Florianne Monnet-Tschudi

4

object named as

Florianne Monnet-Tschudi

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Anders Hallberg

15

object named as

Anders Hallberg

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

10

object named as

Leon A Danyel

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

author name string

Verónica Valero-Esquitino

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Kristin Lucht

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Tobias Stubbe

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Franziska Lucht

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Meng Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Friederike Ebner

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Christine Brandt

9

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Daniel C Villela

11

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Björn Dahlöf

14

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

language of work or name

0 references

publication date

1 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Clinical Science

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

128

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

95-109

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Therapeutic options in multiple sclerosis: five new things

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunity

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Angiotensin II sustains brain inflammation in mice via TGF-beta

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Direct stimulation of angiotensin II type 2 receptor enhances spatial memory

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Protective arms of the renin-angiotensin-system in neurological disease

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

The angiotensin AT2 receptor in inflammation

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Microglial cell activation and proliferation precedes the onset of CNS autoimmunity

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Inflammatory responses in aggregating rat brain cell cultures subjected to different demyelinating conditions

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Nitric oxide synthase expression and nitric oxide toxicity in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Promoting myelin repair and return of function in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Expression of astrocytic type 2 angiotensin receptor in central nervous system inflammation correlates with blood-brain barrier breakdown

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Commercially available angiotensin II At₂ receptor antibodies are nonspecific.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Role of glial cells in innate immunity and their role in CNS demyelination

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Microglia: key innate immune cells of the brain

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

The biology of CNS remyelination: the key to therapeutic advances.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

BDNF: the career of a multifaceted neurotrophin in spinal cord injury

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Microbore liquid chromatography with UV detection to study the in vivo passage of compound 21, a non-peptidergic AT₂ receptor agonist, to the striatum in rats.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

1 reference

https://api.crossref.org/works/10.1042%2FCS20130601

21 January 2018

Identifiers

10.1042/CS20130601

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25052203

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48643095&oldid=2203843253"